Diana Hausman - May 8, 2023 Form 3 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Role
Director
Signature
/s/ Andrea Paul, attorney-in-fact for Diana Hausman
Stock symbol
ZNTL
Transactions as of
May 8, 2023
Transactions value $
$0
Form type
3
Date filed
5/10/2023, 07:11 AM
Previous filing
Jun 23, 2022
Next filing
Jun 15, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney